Table 4 Linear regression analysis (dependent variable: duration of RDV therapy in days)
From: Use of Remdesivir in children with COVID-19: report of an Italian multicenter study
Variable | Beta | C.I. 95% | p-value | |
|---|---|---|---|---|
Lower bound | Upper bound | |||
Sex (male) | 1.313 | -0.009 | 2.635 | 0.052 |
Duration of O2 administration (days) | 0.122 | 0.021 | 0.224 | 0.020 |
Time from pneumonia to RDV administration (days) | 0.336 | -0.047 | 0.719 | 0.083 |
Comorbidity (yes) | 1.793 | 0.219 | 3.367 | 0.027 |